SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

Market speculation regarding an upcoming SpaceX IPO is driving intense community debate, with many investors debating whether high-profile pre-stock tokens and related aerospace entities are legitimate investment opportunities or risky scams. Discussion is largely centered on the massive potential valuation of a public SpaceX debut and its broader impact on the space sector, leading participants to closely scrutinize related stocks and the validity of decentralized crypto tokens claiming affiliation.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

The 4CHAN token is trending as community members position it as the "source code" of internet meme culture, aggressively promoting its potential for explosive growth based on its scarcity and symbolic value. While some critics view it as a high-risk speculative play, proponents are actively buying dips and emphasizing its community-driven, renounced contract as a stable hedge against broader market volatility.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is experiencing significant volatility and downward pressure as investors navigate sector-wide weakness and frustration over the stock's inability to maintain gains despite steady contract wins. While the community is actively debating whether the stock has bottomed or needs more time to heal, many remain bullish on the long-term outlook, highlighting strong fundamental backlog and the company's role in government, nuclear, and space infrastructure as key reasons to maintain their positions.

NEOS ETF Trust - NEOS Nasdaq 100 High Income ETF

NEOS Nasdaq 100 High Income ETF

The NEOS Nasdaq 100 High Income ETF (QQQI) is attracting significant community attention due to its focus on high monthly income and potential tax efficiencies, with many investors actively using it as a foundational piece for building long-term, cash-flow-focused portfolios. Discussions among market participants are centered on comparing its performance and structure against other prominent high-yield options, with a common theme being a long-term 'buy and hold' strategy that utilizes reinvested dividends to compound returns through various market cycles.

Space and Time is the data blockchain securing onchain finance. Backed by Microsoft’s Venture Fund M12, Space and Time connects real-world data to onchain systems to power tokenized assets, stablecoins, institutional markets, and DeFi.  The SXT token is deployed as an ERC-20 token on Ethereum and functions as the network's native utility token. SXT is used for staking, data processing payments, access control, and incentives for data contributors.

Space and Time

Space and Time (SXT) is generating significant community buzz driven by its core infrastructure play in verifiable data, notably bolstered by its backing from Microsoft and its recent mainnet launch. Investors are debating the project's long-term utility in the AI and DeFi sectors, often weighing the potential for institutional adoption against frustration over current price volatility and recent token unlocks.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Assertio Holdings Inc. (ASRT) is trading following the announcement of a $23.50 per share cash tender offer from Zydus Worldwide, which offers a significant premium over prior rejected agreements. The community is actively debating the fairness of this offer, with many long-term shareholders expressing frustration over management's handling of the sales process and advocating for a higher valuation that reflects the company's underlying assets.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

$FARTCOIN is trending as traders debate the viability of meme-based assets, with ongoing community sentiment split between speculative enthusiasm and skepticism regarding its market value. Discussions are heavily focused on the coin's relationship with the broader Solana ecosystem and its frequent comparisons to other meme tokens as retail investors look for the next rapid-growth opportunity.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is currently in focus as investors weigh a wave of M&A activity against broader market volatility driven by geopolitical tensions and shifting interest rate expectations. Community sentiment is deeply divided between long-term bulls highlighting undervalued assets and recent clinical pipeline successes versus those wary of sector-wide technical exhaustion and inflationary headwinds.

Evolution Metals & Technologies Corp. engages in developing a global supply chain for critical minerals and materials. It focuses on automotive, renewable energy, and military and defense sectors. The company is headquartered in West Palm Beach, FL.

Evolution Metals & Technologies Corp.

Evolution Metals & Technologies Corp. Common Stock

Evolution Metals & Technologies is drawing significant investor attention due to its focus on domestic supply chain diversification and recent moves to scale magnet production capacity. Community discussion is heavily focused on the stock's low float and the potential for a short-term squeeze, while also debating the firm's long-term competitive edge in the critical minerals sector.

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

ANI Pharmaceuticals Inc

ANI Pharmaceuticals is experiencing positive momentum driven by strong demand for its rare disease franchise, particularly Cortrophin Gel, and a robust pipeline of new product launches. The community is actively discussing the company's improved financial guidance and strategic efforts to scale its rare disease portfolio, while some remain cautious about broader sector headwinds and historical share price performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immunic (NASDAQ:IMUX) Upgraded by Lifesci Capital to "Strong-Buy" Rating

Lifesci Capital raised shares of Immunic to a "strong-buy" rating in a report on Monday...

HC Wainwright Estimates Immunic's Q1 Earnings (NASDAQ:IMUX)

Immunic, Inc. (NASDAQ:IMUX - Free Report) - Stock analysts at HC Wainwright raised their Q1 2026 earnings per share (EPS) estimates for Immunic in a report issued on Thursday, April 30th. HC Wainwright analyst M. Caufield now anticipates that the company will post earnings of ($0.20) per share for t...

Immunic (IMUX) Projected to Post Quarterly Earnings on Thursday

Immunic (NASDAQ:IMUX) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Immunic to Participate in Investor and Medical Conferences in May

Immunic to Participate in Investor and Medical Conferences in May Immunic to Participate in Investor and Medical Conferences in May PR Newswire NEW YORK, April 30, 2026 NEW YORK, April 30, 2026...

Immunic Appoints Michael Panzara As CMO

(RTTNews) - Immunic, Inc. (IMUX), Tuesday announced the appointment of Michael Panzara, as Chief Medical Officer, succeeding Andreas Muehler, effective April 24, 2026...

Immunic Appoints New Medical Officer To Lead Clinical And Regulatory Strategy

Immunic appoints Michael Panzara as CMO, granting inducement equity award as he takes charge of clinical and regulatory strategy.read more...

Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer

Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara...

Immunic (NASDAQ:IMUX) Stock Price Up 14.1%  - Here's What Happened

Immunic (NASDAQ:IMUX) Shares Up 14.1% - Here's What Happened...

Immunic (NASDAQ:IMUX) Shares to Reverse Split on Monday, April 27th

Immunic, Inc. (NASDAQ:IMUX - Free Report) shares are set to reverse split on Monday, April 27th. The 1-10 reverse split was announced on Thursday, April 23rd. The number of shares owned by...

Immunic, Inc. Announces 1-for-10 Reverse Stock Split

Immunic, Inc. Announces 1-for-10 Reverse Stock Split Immunic, Inc. Announces 1-for-10 Reverse Stock Split PR Newswire NEW YORK, April 23, 2026 NEW YORK, April 23, 2026 /PRNewswire/ -- Immunic, Inc...

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on multiple sclerosis, celiac disease and other neurologic and gastrointestinal disorders. The firm's products include IMU-838, IMU-856, and IMU-381. The company was founded in 2016 and is headquartered in New York, NY.

Current Price	$12.08
Prev Close	$12.66
Open	$12.36
Dividend Yield	0.00%
50-Day Moving Average	$11.39
Beta	1.44
Avg. Volume	319,823.35
PE Ratio	-2.00

52-Week High	$15.10
52-Week Low	$5.06
Market Capitalization	$164.55M
EPS (Annual)	-$6.24
Price to Book	1.09
Revenue Per Employee	$0.00

IMUX
Immunic Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IMUX News

IMUXImmunic Inc